Tetsuaki Arai - Search Results

Year	Number of Results
2001	1
2002	2
2003	6
2004	4
2005	3
2006	6
2007	5
2008	10
2009	19
2010	16
2011	11
2012	6
2013	8
2014	7
2015	6
2016	4
2017	7
2018	12
2019	13
2020	13
2021	3

1

The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.

Kawakami I, Arai T, Hasegawa M. Kawakami I, et al. Among authors: arai t. Acta Neuropathol. 2019 Nov;138(5):751-770. doi: 10.1007/s00401-019-02077-x. Epub 2019 Sep 26. Acta Neuropathol. 2019. PMID: 31555895 Free PMC article. Review.

2

iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease.

Kondo T, Imamura K, Funayama M, Tsukita K, Miyake M, Ohta A, Woltjen K, Nakagawa M, Asada T, Arai T, Kawakatsu S, Izumi Y, Kaji R, Iwata N, Inoue H. Kondo T, et al. Among authors: arai t. Cell Rep. 2017 Nov 21;21(8):2304-2312. doi: 10.1016/j.celrep.2017.10.109. Cell Rep. 2017. PMID: 29166618 Free article.

3

Prion-like spreading of pathological α-synuclein in brain.

Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M. Masuda-Suzukake M, et al. Among authors: arai t. Brain. 2013 Apr;136(Pt 4):1128-38. doi: 10.1093/brain/awt037. Epub 2013 Mar 6. Brain. 2013. PMID: 23466394 Free PMC article.

4

Prion-like properties of pathological TDP-43 aggregates from diseased brains.

Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, Yoshida M, Murayama S, Mann DM, Akiyama H, Hasegawa M. Nonaka T, et al. Among authors: arai t. Cell Rep. 2013 Jul 11;4(1):124-34. doi: 10.1016/j.celrep.2013.06.007. Epub 2013 Jul 3. Cell Rep. 2013. PMID: 23831027 Free article.

5

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T. Arai T, et al. Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11. doi: 10.1016/j.bbrc.2006.10.093. Epub 2006 Oct 30. Biochem Biophys Res Commun. 2006. PMID: 17084815

6

LATE to the PART-y.

Josephs KA, Mackenzie I, Frosch MP, Bigio EH, Neumann M, Arai T, Dugger BN, Ghetti B, Grossman M, Hasegawa M, Herrup K, Holton J, Jellinger K, Lashley T, McAleese KE, Parisi JE, Revesz T, Saito Y, Vonsattel JP, Whitwell JL, Wisniewski T, Hu W. Josephs KA, et al. Among authors: arai t. Brain. 2019 Sep 1;142(9):e47. doi: 10.1093/brain/awz224. Brain. 2019. PMID: 31359030 Free PMC article. No abstract available.

7

Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H. Hasegawa M, et al. Among authors: arai t. Ann Neurol. 2008 Jul;64(1):60-70. doi: 10.1002/ana.21425. Ann Neurol. 2008. PMID: 18546284 Free PMC article.

8

Suicide Prevention Gatekeeper Self-Efficacy Scale (GKSES).

Takahashi A, Tachikawa H, Morita N, Aiba M, Shiratori Y, Nemoto K, Arai T. Takahashi A, et al. Among authors: arai t. Crisis. 2020 Jul 16:1-8. doi: 10.1027/0227-5910/a000698. Online ahead of print. Crisis. 2020. PMID: 32672521

9

Cerebral White Matter Hyperintensity as a Healthcare Quotient.

Park K, Nemoto K, Yamakawa Y, Yamashita F, Yoshida K, Tamura M, Kawaguchi A, Arai T, Sasaki M. Park K, et al. Among authors: arai t. J Clin Med. 2019 Nov 1;8(11):1823. doi: 10.3390/jcm8111823. J Clin Med. 2019. PMID: 31683849 Free PMC article.

10

[The Clinical, Pathological, and Genetic Correlation in Frontotemporal Lobar Degeneration].

Watanabe R, Arai T. Watanabe R, et al. Among authors: arai t. Brain Nerve. 2020 Jun;72(6):575-583. doi: 10.11477/mf.1416201568. Brain Nerve. 2020. PMID: 32507756 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results